Showing 2851-2860 of 9402 results for "".
Erythema Multiforme Major Due to Fluconazole: A Case Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/erythema-multiforme-major-due-to-fluconazole-a-case-report/23887/New in My Practice: OTC Skincare/New Products
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-otc-skincarenew-products/23704/Women in Dermatology: Iris Rubin, MD
https://practicaldermatology.com/topics/practice-management/women-in-dermatology-iris-rubin-md/23589/Considering Going Direct Pay?
https://practicaldermatology.com/topics/practice-management/considering-going-direct-pay/23552/A dermatologist shares thoughts on what “direct care” really means.Update on COVID-19 Vaccines and Dermal Fillers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/update-on-covid-19-vaccines-and-dermal-fillers/23451/CSF faculty discuss risks of delayed facial swelling in filler patients following COVID-19 vaccination.A Case of Pemphigus Foliaceus
https://practicaldermatology.com/topics/infections-infectious-disease/a-case-of-pemphigus-foliaceus/23156/A case-based discussion of an immunobullous disorder.The Showdown: Smartphone vs. DSLR Cameras
https://practicaldermatology.com/topics/practice-management/the-showdown-smartphone-vs-dslr-cameras/23031/Consistently capturing great photos can have a huge impact on your practice. Here’s what to consider.New OTC Topicals Target Hyperpigmentation, Melasma
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-otc-topicals-target-hyperpigmentation-melasma/22081/There's a new and expanding menu of options to improve uneven tone, proving that OTCs can provide benefit for a vexing concern.New in My Practice Rx: Seysara (sarecycline)
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-rx-seysara-sarecycline/20810/Prednisone-induced DRESS Syndrome
https://practicaldermatology.com/topics/general-topics/prednisone-induced-dress-syndrome/21572/This unusual reaction was resolved with a switch to a Group C steroid.